Alyeska Investment Group, L.P. Regeneron Pharmaceuticals, Inc. Transaction History

Alyeska Investment Group, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $37.4 Million - $41.2 Million	41,476 New	41,476 $39.9 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $78.6 Million - $93.2 Million	112,238 New	112,238 $80.6 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $51.5 Million - $55.9 Million	72,964 New	72,964 $52.6 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $4.43 Million - $5.63 Million	-9,258 Reduced 92.58%	742 $358,000
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $18.4 Million - $22.2 Million	-33,692 Reduced 77.11%	10,000 $5.6 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $21.6 Million - $28.1 Million	43,692 New	43,692 $27.2 Million

1,500

83M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.